跳至主要内容
临床试验/NL-OMON56897
NL-OMON56897尚未招募不适用

Feasibility of primer shot radiotherapy for non-small cell lung cancer (PRIMER) - PRIMER

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age >= 18 years
  • NSCLC (either pathology proven or sufficient clinical suspicion to be treated
  • as NSCLC), referred for palliative radiotherapy of at least the primary tumor
  • site (to eleviate or prevent symptoms like shortness of breath, coughing, pain
  • or hemoptysis).
  • NSCLC, stage 2-4
  • WHO performance score 0*2.
  • Provision of signed, written and dated IC prior to any study specific
  • procedures.

排除标准

  • Interstitial lung disease
  • Treatment with vascular endothelial growth factor receptor (VEGFR) inhibitors
  • Prior thoracic radiotherapy (>20 Gy EQD2 a/b 3) overlapping with the current
  • planning target volume

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验

Feasibility of primer shot radiotherapy for... | 临床试验